Cryopreserved saphenous vein allografts in infrainguinal revascularization: analysis of 240 grafts Alik Farber, MD, Kevin Major, MD, Willis H Wagner, MD, J.Louis Cohen, MD, David V Cossman, MD, Stephen R Lauterbach, MD, Philip M Levin, MD Journal of Vascular Surgery Volume 38, Issue 1, Pages 15-21 (July 2003) DOI: 10.1016/S0741-5214(03)00330-6
Fig 1 Indications for 199 primary revascularization procedures with Cryografts. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)
Fig 2 Categorization of 127 secondary procedures after primary revascularization with Cryografts. TPA, Tissue plasminogen activator. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)
Fig 3 Primary patency curve and life table for 199 primary revascularization procedures with Cryografts. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)
Fig 4 Comparison of primary patency rates in grafts with below-knee popliteal (black line) and infrapopliteal (gray line) distal anastomosis (P = NS; Cox multivariate regression analysis). Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)
Fig 5 Effect of diabetes on primary Cryograft patency (P < .05; log-rank test). Gray line, Diabetes; black line, no diabetes. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)
Fig 6 Limb salvage curve and life table for 199 limbs after primary Cryograft revascularization. Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)
Fig 7 Effect of below-knee popliteal (black line) and infrapopliteal (gray line) distal Cryograft anastamosis on limb salvage (P < .05; log-rank test). Journal of Vascular Surgery 2003 38, 15-21DOI: (10.1016/S0741-5214(03)00330-6)